Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)

Launched by THE UNIVERSITY OF HONG KONG · Aug 19, 2020

Keywords

ClinConnect Summary

The HUA-TUO AF Trial is studying a new way to detect a heart condition called atrial fibrillation (AF) in patients who have had a stroke. Atrial fibrillation can increase the risk of having another stroke, but many people don’t know they have it until it’s too late. This trial will test whether using a simple, handheld device to monitor heart rhythms at home can find AF more effectively than the usual methods. The goal is to see if catching AF early can help improve health outcomes for stroke survivors.

To participate in this trial, individuals need to be at least 18 years old and have had an ischemic stroke (the most common type of stroke caused by blocked blood flow) within the past five years. Participants should not have a history of AF or be on long-term blood-thinning medication. Those who join the study will use the handheld device to record their heart rhythms from home over a period of time. This study is not yet recruiting participants, but it aims to gather important information that could help prevent future strokes in people who have already experienced one.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age \>= 18 years
• • history of ischemic stroke within 5 years
• • voluntarily agrees to participate by providing written informed consent
• Exclusion Criteria:
• • previously documented AF and/or atrial flutter
• • long-term anticoagulation therapy
• • short life expectance (\< 1year) due to concomitant medical condition(s)
• • cardiac implantable electronic device
• • inability or refusal to provide inform consent
• • lack of skills in operating simple electronic devices
• • unavailability of a mobile network service in the place of residence